Antoine Yrondi

Dr. Antoine Yrondi

CHU TOULOUSE
+2
orcid

Research Focus & Metrics

Academic Career Length

12Years (2015-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2018 in Brain Stimulation
Verified
Journal Article
Closed access
AYAntoine Yrondi
Antoine Yrondi
MSMarie Sporer
Marie Sporer
PPPatrice Péran
Patrice Péran
LSLaurent Schmitt
Laurent Schmitt
CAChristophe Arbus
Christophe Arbus
ASAnne Sauvaget
Anne Sauvaget

1 October 2017 in La Presse Médicale
Verified
Journal Article
Closed access
AYAntoine Yrondi
Antoine Yrondi
DBDavid Brauge
David Brauge
JLJohanne LeMen
Johanne LeMen
CAChristophe Arbus
Christophe Arbus
JPJérémie Pariente
Jérémie Pariente

23 November 2016 in Acta Neuropsychiatrica
Verified
Journal Article
Closed access
PDF file
AYAntoine Yrondi
Antoine Yrondi
PPPatrice Péran
Patrice Péran
ASAnne Sauvaget
Anne Sauvaget
LSLaurent Schmitt
Laurent Schmitt
CAChristophe Arbus
Christophe Arbus
Objectives: Electroconvulsive therapy (ECT) is a non-pharmacological treatment that is effective in treating severe and treatment-resistant depression. Although the efficacy of ECT has been demonstrated to treat major depressive disorder (MDD), the brain mechanisms underlying this process remain unclear. Structural–functional changes occur with the use of ECT as a treatment for depression based on magnetic resonance imaging (MRI). For this reason, we have tried to identify the changes that were identified by MRI to try to clarify some operating mechanisms of ECT. We focus to brain changes on MRI [structural MRI (sMRI), functional MRI (fMRI) and diffusion tensor imging (DTI)] after ECT.Methods: A systematic search of the international literature was performed using the bibliographic search engines PubMed and Embase. The research focused on papers published up to 30 September 2015. The following Medical Subject Headings (MESH) terms were used: electroconvulsive therapy AND (MRI OR fMRI OR DTI). Papers published in English were included. Four authors searched the database using a predefined strategy to identify potentially eligible studies.Results: There were structural changes according to the sMRI performed before and after ECT treatment. These changes do not seem to be entirely due to oedema. This investigation assessed the functional network connectivity associated with the ECT response in MDD. ECT response reverses the relationship from negative to positive between the two pairs of networks.Conclusion: We found structural–functional changes in MRI post-ECT. Because of the currently limited MRI data on ECT in the literature, it is necessary to conduct further investigations using other MRI technology.

30 January 2020 in Depression and Anxiety
Verified
Journal Article
Closed access
PDF file
AYAntoine Yrondi
Antoine Yrondi
Bruno AouizerateBruno Aouizerate
Bruno Aouizerate
DBDjamila Bennabi
Djamila Bennabi
RRRaphaëlle Richieri
Raphaëlle Richieri
TDThierry D'AMato
Thierry D'AMato
WISSAM EL-HAGEWISSAM EL-HAGE
WISSAM EL-HAGE

1 November 2019 in Journal of Affective Disorders
Verified
Journal Article
Closed access
AYAntoine Yrondi
Antoine Yrondi
FNFederico Nemmi
Federico Nemmi
SBSophie Billoux
Sophie Billoux
AGAurélie Giron
Aurélie Giron
MSMarie Sporer
Marie Sporer
PPPatrice Péran
Patrice Péran

19 September 2019 in Frontiers in Psychiatry
Verified
Journal Article
Open access
PDF file
AYAntoine Yrondi
Antoine Yrondi
FNFederico Nemmi
Federico Nemmi
SBSophie Billoux
Sophie Billoux
AGAurélie Giron
Aurélie Giron
MSMarie Sporer
Marie Sporer
CAChristophe Arbus
Christophe Arbus
Introduction: The hippocampus plays a key role in depressive disorder, and the amygdala is involved in depressive disorder through the key role that it plays in emotional regulation. Electroconvulsive therapy (ECT) may alter the microstructure of these two regions. Since mean diffusivity (MD), is known to be an indirect marker of microstructural integrity and can be derived from diffusion tensor imaging (DTI) scans, we aim to test the hypothesis that treatment-resistant depression (TRD) patients undergoing bilateral (BL) ECT exhibit a decrease of MD in their hippocampus and amygdala. Methods: Patients, between 50 and 70 years of age, diagnosed with TRD were recruited from the University Hospital of Toulouse and assessed clinically (Hamilton Depression Rating Scale, HAM-D) and by DTI scans at three time points: baseline, V2 (during treatment), and V3 within 1 week of completing ECT. Results: We included 15 patients, who were all responders. The left and right hippocampi and the left amygdala showed a significant decrease in MD at V3, compared to baseline [respectively: β = −2.78, t = −1.97, p = 0.04; β = −2.56, t = −2, p = 0.04; β = −2.5, t = −2.3, p = 0.04, false discovery rate (FDR) corrected]. MD did not decrease in the right amygdala. Only the left amygdala was significantly associated with a reduction in HAM-D (ρ = 0.55, p = 0.049, FDR corrected). Conclusion: MD is an indirect microstructural integrity marker, which decreases in the hippocampus and the left amygdala, during BL ECT in TRD populations. This could be interpreted as a normalization of microstructural integrity in these structures.